Roche Announces Thomas Schinecker as New President of 454 Life Sciences

BRANFORD, Conn.--(BUSINESS WIRE)--454 Life Sciences, a center of excellence of Roche’s (SIX: RO, ROG; OTCQX: RHHBY) business unit Applied Science, and developer of the innovative GS Junior and GS FLX+ Systems for high-throughput DNA sequencing, announced that effective August 1, 2011, Dr. Thomas Schinecker is appointed Lifecycle Leader for Sequencing and President of 454 Life Sciences, Inc., in Branford, Connecticut, USA, reporting to Robert Yates, Head of Applied Science.